Does the Prophylactic Use of Palivizumab in Premature Patients With Down Syndrome in Respiratory Syncytial Virus Infection Reduce the Hospitalization Rate? An Integrative Review. RSD 2024, 13 (1), e13513144288. https://doi.org/10.33448/rsd-v13i1.44288.